Review
doi: 10.1016/j.tibtech.2008.04.006.
Epub 2008 Jun 19.
Nanotechnology and aptamers: applications in drug delivery
Affiliations
- PMID: 18571753
- DOI: 10.1016/j.tibtech.2008.04.006
Item in Clipboard
Review
Nanotechnology and aptamers: applications in drug delivery
Trends Biotechnol.
2008 Aug.
Abstract
Nucleic acid ligands, also known as aptamers, are a class of macromolecules that are being used in several novel nanobiomedical applications. Aptamers are characterized by high affinity and specificity for their target, a versatile selection process, ease of chemical synthesis and a small physical size, which collectively make them attractive molecules for targeting diseases or as therapeutics. These properties will enable aptamers to facilitate innovative new nanotechnologies with applications in medicine. In this review, we will highlight recent developments in using aptamers in nanotechnology solutions for treating and diagnosing disease.
Similar articles
-
The chemical biology of aptamers.Angew Chem Int Ed Engl. 2009;48(15):2672-89. doi: 10.1002/anie.200804643. Angew Chem Int Ed Engl. 2009. PMID: 19319884 Review.
-
Complex target SELEX.Acc Chem Res. 2008 Jan;41(1):130-8. doi: 10.1021/ar700142z. Acc Chem Res. 2008. PMID: 18193823 Review.
-
The development and testing of aptamers for cancer.Curr Opin Investig Drugs. 2009 Jun;10(6):572-8. Curr Opin Investig Drugs. 2009. PMID: 19513946 Review.
-
SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.Biomol Eng. 2007 Oct;24(4):381-403. doi: 10.1016/j.bioeng.2007.06.001. Epub 2007 Jun 16. Biomol Eng. 2007. PMID: 17627883 Review.
-
Advances in SELEX and application of aptamers in the central nervous system.Biomol Eng. 2007 Dec;24(6):583-92. doi: 10.1016/j.bioeng.2007.06.003. Epub 2007 Jul 5. Biomol Eng. 2007. PMID: 17681489 Review.
Cited by
-
Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages.Mol Ther Nucleic Acids. 2020 Mar 6;19:157-167. doi: 10.1016/j.omtn.2019.10.042. Epub 2019 Nov 15. Mol Ther Nucleic Acids. 2020. PMID: 31837605 Free PMC article. Review.
-
Cell-specific aptamer-mediated targeted drug delivery.Oligonucleotides. 2011 Feb;21(1):1-10. doi: 10.1089/oli.2010.0264. Epub 2010 Dec 23. Oligonucleotides. 2011. PMID: 21182455 Free PMC article. Review.
-
Design of smart HPMA copolymer-based nanomedicines.J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3. J Control Release. 2016. PMID: 26437260 Free PMC article. Review.
-
Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells.Int J Mol Sci. 2021 Jan 20;22(3):1019. doi: 10.3390/ijms22031019. Int J Mol Sci. 2021. PMID: 33498454 Free PMC article.
-
Anti-VCAM-1 and Anti-IL4Rα Aptamer-Conjugated Super Paramagnetic Iron Oxide Nanoparticles for Enhanced Breast Cancer Diagnosis and Therapy.Molecules. 2020 Jul 29;25(15):3437. doi: 10.3390/molecules25153437. Molecules. 2020. PMID: 32751068 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
